Beam Therapeutics Sues Chinese Firm YolTech and Partner Serapha for Alleged Trade Secret Theft
Beam Therapeutics has filed a lawsuit against the Chinese biotech company YolTech Therapeutics and its U.S. partner, Serapha Bio, alleging that they developed a medicine using stolen trade secrets. The case centers on intellectual property claims related to Beam's proprietary technology in gene editing. Serapha recently completed a reverse merger with Boundless Bio (BOLD), which has drawn attention due to the potential implications for both companies involved and their investors. This legal action could impact ongoing collaborations or partnerships involving Serapha, particularly as it relates to its newly merged entity.
Tickers: $BEAM
Topics: biotech intellectual property lawsuit